The aim of this study was to determine whether in migraine patients with and without aura
early treatment with various triptans leads to differences in pain reduction after 1 h and in …

The objective of the study was to assess the efficacy of 6 mg subcutaneous (SC) sumatriptan
to treat migraine and the relationship between response of migraine and cutaneous …

Objective.—To reexamine the efficacy of terminating migraine headache by administration of
sumatriptan during the visual‐aura phase of the attack. Background.—Although the …

(Headache 2010; 50: 1198‐1200) One can question the clinical relevance of early
headache responses after oral and intranasal triptans. Thus, for pain‐free the early …

The efficacy of triptans in the treatment of migraine was recently contested. How high is then
the maximum effect of a triptan? After subcutaneous naratriptan 10 mg a 88% pain-free …

Early treatment and combining a triptan with a non-steroidal anti-inflammatory drug (NSAID)
are thought to improve outcome during migraine attacks, possibly by counteracting the …

The paradigm of early treatment of the migraine attack at mild pain intensity has become one
alternative to circumventing the problem of compromised oral absorption of symptomatic …

Objective.—The aim of this study was to determine whether clinical indicators of cutaneous
allodynia predict the success of migraine therapy with sumatriptan using a brief …

Although triptans have been proven effective for acute treatment of migraine, reserving them
for moderate or severe pain may produce suboptimal pain relief and higher rates of …

Objective.—This study evaluated the effectiveness of a single fixed‐dose tablet of
sumatriptan 85 mg/naproxen sodium 500 mg (sumatriptan–naproxen) using a very early …